If you are looking at Mounjaro 2.5mg, you are almost certainly at the beginning. Mounjaro 2.5mg is the starting dose used for new patients so your body can adjust to treatment, it is not the dose intended to deliver the full treatment effect. Either deciding whether to start, or about to.
This guide is for UK adults considering or beginning Mounjaro for weight management or type 2 diabetes. It covers what the 2.5mg starting strength is for, why treatment typically begins at 2.5mg for the first four weeks, what the first weeks usually involve, how UK prescribing and eligibility work, what to expect on cost as treatment progresses, and the practical points on storage, delivery, and safety. It does not tell you what dose you should be on, because that is your prescriber's decision, and Mounjaro may be prescribed long term, including for up to two years where clinically appropriate.
What Mounjaro Weight Loss Medication Is
Mounjaro (tirzepatide) is a prescription medicine made by Eli Lilly. It works by activating two natural hormones, GIP and GLP-1, which help regulate blood sugar, control appetite, and influence how the body uses energy. For people using it for weight management, it can help reduce appetite, make you feel full sooner, and support weight loss when combined with healthy lifestyle changes.
It is given as a once-weekly injection using a pre-filled pen, and holds MHRA marketing authorisation for Mounjaro for weight loss alongside diet and physical activity, and separately for type 2 diabetes. Unlike other weight loss injections, it acts on two pathways rather than one. Full details of Mounjaro treatment, including all available strengths, are on our product page.
Clinical trials support long-term use. Mounjaro is prescription-only medicine. Treatment suitability depends on individual clinical assessment.
What the 2.5mg Starting Dose Is For
The starting strength exists to let the body adjust to the medicine during the first month before higher doses are introduced, and the 2.5 mg dose aims to minimise gastrointestinal side effects. Gastrointestinal effects are common with this class of medicine when treatment begins, and starting low is how that is managed.
The practical consequence, and the thing most worth understanding before you begin: 2.5mg is not intended to deliver the treatment's full effect. Its purpose is to help your body adjust to the medicine . Weight change at this stage is often modest, and people who expect otherwise sometimes conclude the treatment is not working and stop before it has had a chance. After the initial 4-weeks period, Mounjaro doses can be increased if appropriate, commonly to 5 mg after the first four weeks.
Your prescriber decides whether, when and how to increase your dose, based on how you respond and tolerate it. Some people move up steadily. Some stay longer at a given strength. Patients typically transition to a maintenance dose after the first month, although the maximum maintenance dose varies by individual response and the maximum dose of Mounjaro is 15 mg per week under prescriber supervision. There is no single correct path, and it is not something to manage yourself.
What the First Weeks Typically Involve
This is the part most pages skip, and it is what people at 2.5mg actually want.
Injections are weekly, on the same day each week, given under the skin with the mounjaro pen. Your prescriber or pharmacist will show you how to inject mounjaro into the stomach, thigh, or upper arm, and the patient information leaflet covers the technique. If you need to change your dosing day, leave at least 72 hours between doses before starting the new weekly schedule.
Side effects are common early. Nausea, changes to appetite, and digestive symptoms are the most frequently reported with this class of medicine, affecting over 10% of users and usually settling within a few weeks, and tend to be most noticeable after starting and after each dose increase. Injection site reactions can include rashes and swelling, and serious side effects include pancreatitis and anaphylaxis. For most people they settle with time. The patient information leaflet lists what to expect and what warrants medical attention, and you should read it before your first dose. Mounjaro may cause low blood sugar when used with other diabetes medications.
Appetite changes may be noticeable before weight changes. Many people report the appetite effect first, even if the current dose has only recently been started.
Review happens before any dose change. Continued supply and any increase require prescriber review, including whether it is appropriate to move to the next dose and how to recognise when a pen has reached its final dose.
If something feels wrong, contact your prescriber or pharmacist rather than stopping or adjusting on your own. If you have a missed dose, take it within 96 hours, otherwise skip it and wait for the next dose. Suspected side effects can be reported through the MHRA Yellow Card scheme.
Eligibility and Mounjaro Prescription Criteria
Prescribers assess against criteria typically including a BMI, weight-related health conditions such as high blood pressure, medical history, current medications and previous weight management attempts. People in the healthy BMI range may not be eligible for this type of prescribing. Assessment is a clinical criteria subject based on medical history and other risk factors, not BMI alone.
Some conditions and circumstances mean tirzepatide is not appropriate, including certain personal or family medical histories, a history of certain thyroid cancers, pregnancy and breastfeeding, and interactions with some medicines. Identifying these is exactly what the assessment exists for, which is why answering fully matters more than being approved.
Switching between different weight loss medications or any weight loss medication may require clinical review rather than assuming treatments are interchangeable. Being declined is not a failed transaction. It means a clinician found something making this treatment unsuitable for you. If that happens, other weight loss treatment options may be appropriate, and your prescriber can tell you which.
How to Start Treatment
- Online consultation as part of a weight loss service, covering medical history, current medications, BMI, previous weight management attempts, and whether treatment fits your wider weight loss plan
- Prescriber review, which may request clarification or decline
- Dispensing by a registered pharmacy against the prescription
- Temperature-controlled delivery, since Mounjaro requires refrigeration
- Ongoing review before continued supply and at any dose change, with ongoing support included as treatment progresses
Assessment often completes within a day or two. If questions come up about how the weight loss service works, check the FAQs or support resources for weight loss answers. A provider promising supply without meaningful assessment is cutting the step that protects you.
This may also form part of a weight loss package with guidance on eating habits and regular exercise, including an exercise plan to aid weight loss alongside medication.
Before choosing any provider, check it is registered with the General Pharmaceutical Council, with a number you can verify yourself on the GPhC-register, that a named prescriber is accountable, that it has a UK address, and that it will not supply without a prescription.
What 2.5mg Costs, and What Happens After the Maintenance Dose
Mounjaro cost varies between UK pharmacies for legitimate reasons: purchasing terms, whether consultation and prescriber review are included, whether needles and sharps disposal are covered, and delivery method.
The important point at this stage is that 2.5mg is usually the lowest-priced strength.Cost rises as your dose is increased. Budgeting on the starting price will understate what treatment costs over a year, and a provider who is cheapest at 2.5mg may not be cheapest higher up.
For example, a first 2.5mg pen may start at £149, later 2.5mg orders can be £169, 5mg can cost £199 per month, and the maximum dose can reach £319 per month.
When comparing providers, ask for pricing at every strength they supply, not just this one, confirm exactly what is included, and compare like-for-like with other weight loss treatments.
Tirzepatide is under patent, so there is no generic and no licensed cheaper version. Every UK pharmacy buys the same product through the same regulated supply chain, which is why genuine prices cluster within a narrow band. If you see offers that bundle weight loss treatments, still check the full dose-range pricing and whether each supply includes a prescriber review. If a price is much lower than those offered by regulated UK providers, check carefully that the medicine is licensed and supplied through a regulated pharmacy.
How to Store Mounjaro and Delivery Information
To store Mounjaro, keep the Mounjaro pen refrigerated. The permitted range, the time allowed outside the fridge, and in-use limits after first use are set out in the Summary of Product Characteristics. Do not freeze it, and do not use a pen that has frozen.
This is why temperature-controlled delivery matters. A pen shipped in ordinary packaging in warm weather may have gone outside its storage range with no visible sign.
Supply and Continuity
Availability of GLP-1 medicines has fluctuated since launch, with individual strengths intermittently constrained. This matters from the start, because an interruption can mean restarting at a lower dose under prescriber guidance. Continuity matters because weight loss injections work best when supply is consistent and dose changes are reviewed clinically.
Ask any provider what they hold and how they handle supply gaps, including whether they can supply the strength above yours when the time comes and whether you should plan refills before your next dose so treatment is not interrupted.
